Details for New Drug Application (NDA): 207833
✉ Email this page to a colleague
The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 207833
Tradename: | ATOVAQUONE |
Applicant: | Chartwell Rx |
Ingredient: | atovaquone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 207833
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATOVAQUONE | atovaquone | SUSPENSION;ORAL | 207833 | ANDA | Chartwell RX, LLC | 62135-528 | 62135-528-09 | 210 mL in 1 BOTTLE (62135-528-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 750MG/5ML | ||||
Approval Date: | Apr 28, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription